The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Enhancing the vascularization of three‐dimensional porous alginate scaffolds by incorporating controlled release basic fibroblast growth factor microspheres
Abstract
Site‐specific delivery of angiogenic growth factors from tissue‐engineered devices should provide an efficient means of stimulating localized vessel recruitment to the cell transplants and would ensure cell survival and function. In the present article, we describe the construction of a novel porous alginate scaffold that incorporates tiny poly (lactic‐co‐glycolic acid) microspheres capable of controlling the release of angiogenic factors, such as basic fibroblast growth factor (bFGF). The microspheres are an integral part of the solid alginate matrix, and their incorporation does not affect the scaffold porosity or pore size. In vitro, bFGF was released from the porous composite scaffolds in a controlled manner and it was biologically active as assessed by its ability to induce the proliferation of cardiac fibroblasts. The controlled delivery of bFGF from the three‐dimensional scaffolds accelerated the matrix vascularization after implantation on the mesenteric membrane in rat peritoneum. The number of penetrating capillaries into the bFGF‐releasing scaffolds was nearly fourfold higher than into the control scaffolds (those incorporating microspheric BSA and heparin but not bFGF). At day 10 posttransplantation, capillary density in the composite scaffolds was 45 ± 3/mm 2 and it increased to 70 ± 7/mm 2 by day 21. The released bFGF induced the formation of large and matured blood vessels, as judged by the massive layer of mural cells surrounding the endothelial cells. The control over bFGF delivery and localizing its effects to areas of need, may aid in the wider application of bFGF in therapeutic angiogenesis as well as in tissue engineering. © 2003 Wiley Periodicals, Inc. J Biomed Mater Res 65A: 489–497, 2003
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Langer, R., & Vacanti, J. P. (1993) · Science · doi:10.1126/science.8493529 · Cited by 9,893
THE HEPARIN-BINDING (FIBROBLAST) GROWTH FACTOR FAMILY OF PROTEINS
Burgess, W. H., & Maciag, T. (1989) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.58.070189.003043 · Cited by 1,928
Polymeric system for dual growth factor delivery
Richardson, T. P., Peters, M. C., Ennett, A. B., & Mooney, D. J. (2001) · Nature Biotechnology · doi:10.1038/nbt1101-1029 · Cited by 1,752
Leakage-Resistant Blood Vessels in Mice Transgenically Overexpressing Angiopoietin-1
Thurston, G., Suri, C., Smith, K., McClain, J., Sato, T. N., Yancopoulos, G. D., & McDonald, D. M. (1999) · Science · doi:10.1126/science.286.5449.2511 · Cited by 1,359
Vacanti, J. P., & Langer, R. (1999) · The Lancet · doi:10.1016/s0140-6736(99)90247-7 · Cited by 1,323
Structural Characterization and Biological Functions of Fibroblast Growth Factor
GOSPODAROWICZ, D., FERRARA, N., SCHWEIGERER, L., & NEUFELD, G. (1987) · Endocrine Reviews · doi:10.1210/edrv-8-2-95 · Cited by 1,273
Self-citationBenjamin, L. E., Hemo, I., & Keshet, E. (1998) · Development · doi:10.1242/dev.125.9.1591 · Cited by 1,265
Heparin protects basic and acidic FGF from inactivation
Gospodarowicz, D., & Cheng, J. (1986) · Journal of Cellular Physiology · doi:10.1002/jcp.1041280317 · Cited by 853
Controlled Delivery Systems for Proteins Based on Poly(Lactic/Glycolic Acid) Microspheres
Cohen, S., Yoshioka, T., Lucarelli, M., Hwang, L. H., & Langer, R. (1991) · Pharmaceutical Research · doi:10.1023/a:1015841715384 · Cited by 843
Self-citationImplantable biohybrid artificial organs
Colton, C. (1995) · Cell Transplantation · doi:10.1016/0963-6897(95)00025-s · Cited by 586
Bioengineered Cardiac Grafts : A New Approach to Repair the Infarcted Myocardium?
Leor, J., Aboulafia-Etzion, S., Dar, A., Shapiro, L., Barbash, I. M., Battler, A., Granot, Y., & Cohen, S. (2000) · Circulation · doi:10.1161/01.cir.102.suppl_3.iii-56 · Cited by 558
Self-citationNovel alginate sponges for cell culture and transplantation
Shapiro, L., & Cohen, S. (1997) · Biomaterials · doi:10.1016/s0142-9612(96)00181-0 · Cited by 495
Self-citationHepatocyte behavior within three-dimensional porous alginate scaffolds
Glicklis, R., Shapiro, L., Agbaria, R., Merchuk, J. C., & Cohen, S. (2000) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(20000205)67:3<344::aid-bit11>3.0.co;2-2 · Cited by 391
Self-citationOptimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds
Dar, A., Shachar, M., Leor, J., & Cohen, S. (2002) · Biotechnology and Bioengineering · doi:10.1002/bit.10372 · Cited by 384
Self-citationControlled and modulated release of basic fibroblast growth factor
Edelman, E. R., Mathiowitz, E., Langer, R., & Klagsbrun, M. (1991) · Biomaterials · doi:10.1016/0142-9612(91)90107-l · Cited by 363
Baird, A., & Böhlen, P. (1991) · Springer eBooks · doi:10.1007/978-1-4612-3210-0_7 · Cited by 355
Zmora, S., Glicklis, R., & Cohen, S. (2002) · Biomaterials · doi:10.1016/s0142-9612(02)00146-1 · Cited by 297
Self-citationThree-dimensional structure of human basic fibroblast growth factor.
Eriksson, A. E., Cousens, L. S., Weaver, L. H., & Matthews, B. W. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.8.3441 · Cited by 284
Edelman, E. R., Nugent, M. A., & Karnovsky, M. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.4.1513 · Cited by 266
Masaki, I., Yonemitsu, Y., Yamashita, A., Sata, S., Tanii, M., Komori, K., Nakagawa, K., Hou, X., Nagai, Y., Hasegawa, M., et al. (2002) · Circulation Research · doi:10.1161/01.res.0000019540.41697.60 · Cited by 240
Injectable Alginate Seeded with Chondrocytes as a Potential Treatment for Vesicoureteral Reflux
Atala, A., Griffith, L. G., Kim, W. S., Paige, K. T., Vacanti, J. P., Retik, A. B., & Vacanti, C. A. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)35603-3 · Cited by 231
Tanihara, M., Suzuki, Y., Yamamoto, E., Noguchi, A., & Mizushima, Y. (2001) · Journal of Biomedical Materials Research · doi:10.1002/1097-4636(200108)56:2<216::aid-jbm1086>3.0.co;2-n · Cited by 206
Baird, A., & Walicke, P. A. (1989) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a072333 · Cited by 199
Binding and release of basic fibroblast growth factor from heparinized collagen matrices
Wissink, M., Beernink, R. H. J., Pieper, J., Poot, A. A., Engbers, G. H. M., Beugeling, T., van Aken, W. G., & Feijén, J. (2001) · Biomaterials · doi:10.1016/s0142-9612(00)00418-x · Cited by 175
The Fate of Intravenously Administered bFGF and the Effect of Heparin
Whalen, G. F., Shing, Y., & Folkman, J. (1989) · Growth Factors · doi:10.3109/08977198909029125 · Cited by 155
Dinbergs, I. D., Brown, L. R., & Edelman, E. R. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29822 · Cited by 123
Characterization of PLGA microspheres for the controlled delivery of IL-1α for tumor immunotherapy
Chen, L., Apte, R. N., & Cohen, S. (1997) · Journal of Controlled Release · doi:10.1016/s0168-3659(96)01496-4 · Cited by 115
Self-citationRusnati, M., Coltrini, D., Caccia, P., Dell’Era, P., Zoppetti, G., Oreste, P., Valsasina, B., & Presta, M. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2203 · Cited by 97
Stoichiometry of Heparin Binding to Basic Fibroblast Growth Factor
Arakawa, T., Wen, J., & Philo, J. S. (1994) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1994.1037 · Cited by 57
Brain-derived fibroblast growth factor: A study of its inactivation
Westall, F. C., Rubin, R., & Gospodarowicz, D. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90636-7 · Cited by 50
Cited by
Mano, J. F., Silva, G. A., Azevedo, H. S., Malafaya, P. B., Sousa, R. A., Silva, S. S., Boesel, L. F., Oliveira, J. M., Santos, T. C., Marques, A. P., et al. (2007) · Journal of The Royal Society Interface · doi:10.1098/rsif.2007.0220 · Cited by 1,140
Vascularization is the key challenge in tissue engineering
Novosel, E. C., Kleinhans, C., & Kluger, P. J. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.03.004 · Cited by 1,062
Vascularization Strategies for Tissue Engineering
Lovett, M., Lee, K., Edwards, A., & Kaplan, D. L. (2009) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2009.0085 · Cited by 923
Liu, Z., Meyers, M. A., Zhang, Z., & Ritchie, R. O. (2017) · Progress in Materials Science · doi:10.1016/j.pmatsci.2017.04.013 · Cited by 895
Fibroblast Growth Factors: Biology, Function, and Application for Tissue Regeneration
Yun, Y.-R., Won, J. E., Jeon, E., Lee, S., Kang, W., Jo, H., Jang, J.-H., Shin, U. S., & Kim, H.-W. (2010) · Journal of Tissue Engineering · doi:10.4061/2010/218142 · Cited by 712
Metadata
- Authors
- Perets, A., Baruch, Y., Weisbuch, F., Shoshany, G., Neufeld, G., & Cohen, S.
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2003-05-13
- Volume
- 65A
- Issue
- 4
- Pages
- 489-497
- ISSN
- 1549-3296 (ISSN-L)
- 1552-4965
- OpenAlex
- W2154303934
- Cited by
- 439
- References
- 30
- FWCI
- 20.06
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.